全文获取类型
| 收费全文 | 947208篇 |
| 免费 | 68725篇 |
| 国内免费 | 1533篇 |
专业分类
| 耳鼻咽喉 | 13177篇 |
| 儿科学 | 24919篇 |
| 妇产科学 | 23660篇 |
| 基础医学 | 135166篇 |
| 口腔科学 | 28445篇 |
| 临床医学 | 81854篇 |
| 内科学 | 186212篇 |
| 皮肤病学 | 19532篇 |
| 神经病学 | 73404篇 |
| 特种医学 | 37334篇 |
| 外国民族医学 | 80篇 |
| 外科学 | 154213篇 |
| 综合类 | 18494篇 |
| 现状与发展 | 1篇 |
| 一般理论 | 255篇 |
| 预防医学 | 64367篇 |
| 眼科学 | 21761篇 |
| 药学 | 73542篇 |
| 5篇 | |
| 中国医学 | 2297篇 |
| 肿瘤学 | 58748篇 |
出版年
| 2018年 | 9546篇 |
| 2017年 | 7446篇 |
| 2016年 | 8204篇 |
| 2015年 | 9368篇 |
| 2014年 | 12659篇 |
| 2013年 | 18449篇 |
| 2012年 | 25451篇 |
| 2011年 | 26425篇 |
| 2010年 | 15647篇 |
| 2009年 | 14918篇 |
| 2008年 | 25629篇 |
| 2007年 | 26775篇 |
| 2006年 | 27509篇 |
| 2005年 | 26284篇 |
| 2004年 | 25375篇 |
| 2003年 | 24353篇 |
| 2002年 | 23807篇 |
| 2001年 | 55028篇 |
| 2000年 | 56798篇 |
| 1999年 | 47168篇 |
| 1998年 | 10827篇 |
| 1997年 | 9559篇 |
| 1996年 | 9659篇 |
| 1995年 | 8990篇 |
| 1994年 | 8344篇 |
| 1993年 | 7634篇 |
| 1992年 | 35605篇 |
| 1991年 | 34017篇 |
| 1990年 | 32861篇 |
| 1989年 | 32011篇 |
| 1988年 | 29100篇 |
| 1987年 | 28366篇 |
| 1986年 | 26375篇 |
| 1985年 | 25227篇 |
| 1984年 | 17896篇 |
| 1983年 | 15192篇 |
| 1982年 | 7816篇 |
| 1981年 | 6798篇 |
| 1979年 | 15823篇 |
| 1978年 | 10614篇 |
| 1977年 | 9068篇 |
| 1976年 | 7887篇 |
| 1975年 | 8656篇 |
| 1974年 | 10482篇 |
| 1973年 | 9880篇 |
| 1972年 | 9376篇 |
| 1971年 | 8866篇 |
| 1970年 | 8442篇 |
| 1969年 | 7930篇 |
| 1968年 | 7210篇 |
排序方式： 共有10000条查询结果，搜索用时 750 毫秒
131.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217
132.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
133.
Joseph M. Northey Kate L. Pumpa Clare Quinlan Ashley Ikin Kellie Toohey Disa J. Smee Ben Rattray 《Journal of Science and Medicine in Sport》2019,22(5):580-585
Objectives
The current study investigated the effects of two exercise interventions on cognitive function amongst breast cancer survivors.Design
Pilot randomised-controlled trial.Methods
Seventeen female cancer survivors (mean: 62.9 ± 7.8 years) were randomised into three groups: high-intensity interval training (HIIT, n = 6); moderate-intensity continuous training (MOD, n = 5); or wait-list control (CON, n = 6). The HIIT and MOD groups exercised on a cycle ergometer 3 days/week for 12-weeks. Primary outcomes were cognitive function assessments utilising CogState. Secondary outcomes were resting middle cerebral artery blood flow velocity, cerebrovascular reactivity and aerobic fitness (VO2peak). Data were analysed with General Linear Mixed Models and Cohen’s d effect sizes were calculated.Results
All 17 participants who were randomised were available for follow-up analysis and adherence was similar for HIIT and MOD (78.7 ± 13.2% vs 79.4 ± 12.0%; p = 0.93). Although there were no significant differences in the cognitive and cerebrovascular outcomes, HIIT produced moderate to large positive effects in comparison to MOD and CON for outcomes including episodic memory, working memory, executive function, cerebral blood flow and cerebrovascular reactivity. HIIT significantly increased VO2peak by 19.3% (d = 1.28) and MOD had a non-significant 5.6% (d = 0.72) increase, compared to CON which had a 2.6% decrease.Conclusions
This study provides preliminary evidence that HIIT may be an effective exercise intervention to improve cognitive performance, cerebrovascular function and aerobic fitness in breast cancer survivors. Considering the sample size is small, these results should be confirmed through larger clinical trials. 相似文献134.
135.
136.
137.
138.
Die Anaesthesiologie - Das Management des schwierigen Atemwegs ist eine präklinische Schlüsselqualifikation. Für Notärzte mit hohem Erfahrungsgrad im Atemwegsmanagement sind... 相似文献
139.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献140.
K. A. Harding M. E. Pushpanathan S. R. Whitworth S. Nanthakumar R. S. Bucks T. C. Skinner 《Diabetic medicine》2019,36(12):1600-1611